NG
Nikhil Gupta
About Nikhil Gupta
Data last updated:
Nikhil Gupta is a Director at Wave Pharmaceuticals Limited (since 2017) and Additional Director at Iwave Pharmaceuticals Private Limited (since 2025). The companies operate in Pharma and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹2.22 Cr; the largest is Wave Pharmaceuticals Limited at ₹1.93 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Jan 2017 | 1997 | ₹1.93 Cr (FY 2023) | Active | |
| Additional Director | 26 Nov 2025 | 2019 | ₹29.1 Lakh (FY 2022) | Active |
Board colleagues of Nikhil Gupta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sanjay Gupta | 07728506 | Wave Pharmaceuticals Limited , Iwave Pharmaceuticals Private Limited | Director |
| Sarita Gupta | 07944582 | Wave Pharmaceuticals Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nikhil Gupta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nikhil Gupta
Nikhil Gupta currently holds 2 directorships: Wave Pharmaceuticals Limited (Director, since 28 Jan 2017, revenue ₹1.93 Cr (FY 2023)); Iwave Pharmaceuticals Private Limited (Additional Director, since 26 Nov 2025, revenue ₹29.1 Lakh (FY 2022)).
Nikhil Gupta was first appointed on 28 Jan 2017 as Director at Wave Pharmaceuticals Limited. The most recent appointment on record is 26 Nov 2025 at Iwave Pharmaceuticals Private Limited.
The 2 current companies of Nikhil Gupta that report revenue have a combined latest revenue of ₹2.22 Cr: Wave Pharmaceuticals Limited ₹1.93 Cr (FY 2023); Iwave Pharmaceuticals Private Limited ₹29.1 Lakh (FY 2022).
The current boards of Nikhil Gupta's companies include Sanjay Gupta (Wave Pharmaceuticals Limited), Sarita Gupta (Wave Pharmaceuticals Limited).